Company profile
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
- Industry
- Biotechnology Research
- Employees
- 136
- Headquarters
- South San Francisco, California
- Founded
- 2014
- LinkedIn followers
- 11,891
- Office locations
- 2
ORIC Pharmaceuticals Inc. company summary
ORIC Pharmaceuticals Inc. is a company in the Biotechnology Research industry, headquartered in South San Francisco, California, founded in 2014. On LinkedIn the company has around 136 employees and 11,891 followers. The company lists 2 office locations. Its listed specialties include Cancer Resistance, Immunotherapy, Oncology.
What technology does ORIC Pharmaceuticals Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ORIC Pharmaceuticals Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) Enozertinib (ORIC-114), a brain penetrant inhibitor designed to selectively target EGFR exon 20, HER2 exon 20 and EGFR atypical mutations in NSCLC. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
Specialties
Where is ORIC Pharmaceuticals Inc. located?
ORIC Pharmaceuticals Inc. lists 2 office locations.
Compare companies similar to ORIC Pharmaceuticals Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ORIC Pharmaceuticals Inc. oricpharma.com | Biotechnology Research | 136 | 2014 | South San Francisco, California |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ORIC Pharmaceuticals Inc.
What does ORIC Pharmaceuticals Inc. do?
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) Enozertinib (ORIC-114), a brain penetrant inhibitor designed to selectively target EGFR exon 20, HER2 exon 20 and EGFR atypical mutations in NSCLC. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.
How many employees does ORIC Pharmaceuticals Inc. have?
ORIC Pharmaceuticals Inc. has around 136 employees on LinkedIn.
Where is ORIC Pharmaceuticals Inc. headquartered?
ORIC Pharmaceuticals Inc. is headquartered in South San Francisco, California.
Where does ORIC Pharmaceuticals Inc. have offices?
ORIC Pharmaceuticals Inc. lists 2 office locations, including South San Francisco, California, US; San Diego, CA, US.
When was ORIC Pharmaceuticals Inc. founded?
ORIC Pharmaceuticals Inc. was founded in 2014.
Build a lead list from companies like ORIC Pharmaceuticals Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.